openPR Logo
Press release

Multi Cancer Early Detection Market will Exceed US$ 3,934.79 Million by with a projected CAGR of 16.7% from 2024 to 2032

06-26-2024 01:53 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Multi-cancer Early Detection Market

Multi-cancer Early Detection Market

๐“๐ก๐ž ๐ซ๐ž๐œ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฉ๐ฎ๐›๐ฅ๐ข๐ฌ๐ก๐ž๐ ๐Œ๐ฎ๐ฅ๐ญ๐ข ๐‚๐š๐ง๐œ๐ž๐ซ ๐„๐š๐ซ๐ฅ๐ฒ ๐ƒ๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฏ๐ž๐š๐ฅ๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐”๐’๐ƒ ๐Ÿ—๐Ÿ•๐Ÿ–.๐Ÿ”๐Ÿ‘ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ๐Ÿ”.๐Ÿ•% ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ. ๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐จ๐Ÿ๐Ÿ๐ž๐ซ ๐š๐ง ๐š๐›๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ž ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐จ๐Ÿ ๐”๐’๐ƒ ๐Ÿ‘,๐Ÿ—๐Ÿ‘๐Ÿ’.๐Ÿ•๐Ÿ— ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

In the healthcare sector, MCED investigations have become a crucial screening instrument with molecular inspection of tumour connected barometers in bodily fluids with progressive artificial intelligence algorithms. This new approach sanctions the concurrent perception of several cancers while accurately deciding the particular cancer type. Speedily progressing AI technology, the amalgamation of MCED with AI, has surfaced as an eminent trend, inspiring the advancement of the manifold gamut of MCED AI commodities.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/multi-cancer-early-detection-market/request-for-sample

MCED tests are outlined to recognize the premature existence of a broad gamut of cancers. The blood tests intend to discover biomarkers that may indicate the existence of cancer probably prior to current confirmed screening practices detecting it or prior to patients initially available with indications. While MCED examinations are yet in advance, they could, in due course, become exclusive screening and supportive diagnostic instruments. The objectives of MCED tests are factual, discover cancer prematurely which can permit for more efficacious cure enhancing existence rate and finally life cycle.

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐‚๐จ๐ฏ๐ž๐ซ๐ž๐

The market is splintered. The continuing augmentation capability involving alliances, acquisitions, and participation is pushing contention in the marketplace. Some of the companies that are currently dominating the multi cancer early detection market are:
โ€ข Illumina, Inc. (GRAIL, LLC)
โ€ข Exact Sciences Corp.
โ€ข Foundation Medicine, Inc.
โ€ข AnchorDx
โ€ข Guardant Health
โ€ข Burning Rock Biotech Ltd.
โ€ข GENECAST
โ€ข Beijing Lyman Juntai International Medical Technology Development Co.
โ€ข Freenome Holdings, Inc.
โ€ข Elypta AB

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/3926/2

๐Š๐ž๐ฒ ๐“๐š๐ค๐ž๐š๐ฐ๐š๐ฒ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

โ€ข The primary factors propelling the market growth of the multi cancer early detection are the accompanying prevalent customary screening processes and the sustenance of escalated precision levels.
โ€ข The multi cancer early detection market analysis is mainly based on type, end user and region.
โ€ข In 2023, North America dominated the market.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ

๐˜ฝ๐™ฎ ๐™๐™ฎ๐™ฅ๐™š :

โ€ข Liquid Biopsy
โ€ข Gene Panel, LDT
โ€ข Others

๐˜ฝ๐™ฎ ๐™€๐™ฃ๐™™ ๐™๐™จ๐™š๐™ง :

โ€ข Hospitals
โ€ข Diagnostic Laboratories
โ€ข Others

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐€๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/multi-cancer-early-detection-market

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

๐™.๐™Ž. ๐™Š๐™ง๐™ฉ๐™๐™ค๐™ฅ๐™š๐™™๐™ž๐™˜ ๐˜ฟ๐™š๐™ซ๐™ž๐™˜๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/us-orthopedic-devices-market
๐™„๐™ฃ๐™™๐™ช๐™จ๐™ฉ๐™ง๐™ž๐™–๐™ก ๐™ˆ๐™ž๐™˜๐™ง๐™ค๐™—๐™ž๐™ค๐™ก๐™ค๐™œ๐™ฎ ๐™๐™š๐™จ๐™ฉ๐™ž๐™ฃ๐™œ ๐™Ž๐™š๐™ง๐™ซ๐™ž๐™˜๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/industrial-microbiology-testing-services-market
๐™๐™ก๐™ฉ๐™ง๐™–๐™จ๐™ค๐™ช๐™ฃ๐™™ ๐™‰๐™š๐™š๐™™๐™ก๐™š ๐™‚๐™ช๐™ž๐™™๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/ultrasound-needle-guides-market
๐™ˆ๐™š๐™ฉ๐™–๐™ซ๐™š๐™ง๐™จ๐™š ๐™ž๐™ฃ ๐™ƒ๐™š๐™–๐™ก๐™ฉ๐™๐™˜๐™–๐™ง๐™š ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/metaverse-in-healthcare-market
๐˜ฝ๐™ค๐™ฃ๐™š ๐™‚๐™ง๐™ค๐™ฌ๐™ฉ๐™ ๐™Ž๐™ฉ๐™ž๐™ข๐™ช๐™ก๐™–๐™ฉ๐™ค๐™ง ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/bone-growth-stimulator-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multi Cancer Early Detection Market will Exceed US$ 3,934.79 Million by with a projected CAGR of 16.7% from 2024 to 2032 here

News-ID: 3554689 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expanding at a strong CAGR of 19.88% during the forecast period from 2026 to 2034.
Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expan โ€ฆ
The global mobile biometrics market is projected to be valued at approximately USD 53.10 billion in 2025 and is expected to witness strong growth through 2034, driven by rising concerns over data security, increasing smartphone-based digital transactions, and the growing adoption of biometric authentication across banking, enterprise, and government sectors. The market is anticipated to expand at a CAGR of 19.88% during the forecast period, reaching an estimated value ofโ€ฆ
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During 2026-2034 | AbbVie Inc., Croma-Pharma GmbH, Hugel, Inc.
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During โ€ฆ
Polaris Market Research recently introduced the latest update on Bioregenerative Aesthetic Injectables Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Bioregenerative Aesthetic Injectables Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of theโ€ฆ
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a 2.29% CAGR from 2026 to 2034
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a โ€ฆ
Global Copper Mining Market is currently valued at USD 191.96 Billion in 2025 and is anticipated to generate an estimated revenue of USD 235.28 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.29% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titled Copperโ€ฆ
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, Expanding at a 4.9% CAGR from 2026 to 2034
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, โ€ฆ
Global Specialty Oilfield Chemicals Market is currently valued at USD 11.0 Billion in 2025 and is anticipated to generate an estimated revenue of USD 16.7 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titledโ€ฆ

All 5 Releases


More Releases for MCED

Global Multi-Cancer Early Detection (MCED) Market Size, Share, Growth Trends, an โ€ฆ
The global multi-cancer early detection (MCED) market was valued at USD 0.8 billion in 2025 and is projected to reach USD 8.4 billion by 2036, growing from an estimated USD 1.2 billion in 2026 at a CAGR of 21.2% during the forecast period. The market is expanding rapidly because healthcare systems around the world are increasingly focusing on the early identification of cancer to improve survival outcomes and reduce theโ€ฆ
United States Multi Cancer Early Detection Testing Market to hit US$ 3.06 Billio โ€ฆ
The global Multi Cancer Early Detection Testing Market reached US$ 2.24 billion in 2025 and is expected to reach US$ 10.22 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2026-2033. Growth is driven by increasing prevalence of cancer and rising demand for early diagnostic solutions. Advancements in genomic technologies and liquid biopsy techniques are accelerating market expansion. The growing focus on preventive healthcare and personalizedโ€ฆ
Multi Cancer Early Detection Market to Accelerate as Liquid Biopsy, AI-Based Sig โ€ฆ
Austin, Texas, April 28, 2026: DataM Intelligence has released its latest analysis on the Multi Cancer Early Detection Market, highlighting rapid growth as healthcare systems, diagnostic laboratories, oncology platforms and preventive screening providers increase focus on non-invasive cancer detection. According to DataM Intelligence, the global multi cancer early detection market stood at US$ 4.72 billion in 2025 and is projected to reach US$ 32.75 billion by 2035, growing at aโ€ฆ
Multi-Cancer Early Detection Testing Market to Reach USD 7.52 Billion by 2033 at โ€ฆ
The global multi-cancer early detection (MCED) testing market reached USD 1.67 billion in 2023, increasing to USD 1.92 billion in 2024, and is expected to reach USD 7.52 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025 to 2033. The market is witnessing rapid growth driven by the increasing emphasis on early cancer detection and the rising global burden of cancer. Market growth is fueled byโ€ฆ
Multi-Cancer Early Detection (MCED) Testing Market to Reach US$ 7.52 Billion by โ€ฆ
The multi-cancer early detection (MCED) testing market reached US$ 1.67 billion in 2023, increased to US$ 1.92 billion in 2024, and is projected to reach US$ 7.52 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033. The market is gaining strong momentum as healthcare systems shift toward preventive oncology and population-level cancer screening. Multi-cancer early detection testing leverages advanced technologies such as liquid biopsy, next-generation sequencing,โ€ฆ
Multi-Cancer Early Detection: Transforming Cancer Screening with Cutting-Edge Bl โ€ฆ
๐Ÿ‘‰ Multi-cancer early detection (MCED) is a breakthrough blood test that screens for many types of cancer at once, unlike traditional methods targeting one cancer type. It detects cancer signals before symptoms appear, enabling earlier treatment and improving survival rates. This approach offers broader, earlier diagnosis to save more lives. โœ… Download Free Sample: https://www.datamintelligence.com/download-sample/multi-cancer-early-detection-testing-market?rk ๐Ÿ’ก How Do Multi-cancer early detection Tests Work? MCED tests analyze biological markers such as circulating tumorโ€ฆ